Preeclampsia Screening: Evidence Report and Systematic Review for the US Preventive Services Task Force

@article{Henderson2017PreeclampsiaSE,
  title={Preeclampsia Screening: Evidence Report and Systematic Review for the US Preventive Services Task Force},
  author={J. Henderson and Jamie H. Thompson and B. Burda and Amy Cantor},
  journal={JAMA},
  year={2017},
  volume={317},
  pages={1668–1683}
}
  • J. Henderson, Jamie H. Thompson, +1 author Amy Cantor
  • Published 2017
  • Medicine
  • JAMA
  • Importance Preeclampsia is a complex disease of pregnancy with sometimes serious effects on maternal and infant morbidity and mortality. It is defined by hypertension after 20 weeks’ gestation and proteinuria or other evidence of multisystem involvement. Objective To systematically review the benefits and harms of preeclampsia screening and risk assessment for the US Preventive Services Task Force. Data Sources MEDLINE, PubMed, and Cochrane Central Register of Controlled Trials databases from… CONTINUE READING
    55 Citations
    Screening for Preeclampsia: Recommendation Statement.
    • Medicine
    • American family physician
    • 2018
    First trimester preeclampsia screening and prediction.
    • 2

    References

    SHOWING 1-10 OF 104 REFERENCES
    Committee Opinion No. 638: First-Trimester Risk Assessment for Early-Onset Preeclampsia.
    • Medicine
    • Obstetrics and gynecology
    • 2015
    • 22
    Protein/Creatinine Ratio in Preeclampsia: A Systematic Review
    • 73
    • PDF
    A Competing Risks Model in Early Screening for Preeclampsia
    • 160
    • PDF